DXN's investor relations keep shareholders informed about the company's progress and plans
Cyberjaya, 18 June 2025 - DXN Holdings Bhd. (“DXN” or the “Company”) [德信控股], a global manufacturer of health focused nutraceutical products, is thrilled to announce its inclusion in the inaugural Fortune Southeast Asia 500 list, debuting at No. 491. This prestigious recognition marks a proud and significant milestone for the Malaysian Company and its global subsidiaries (“DXN Group” or the “Group”), highlighting its strong growth momentum since its inception in 1993, focused strategic execution and successful international expansion.
The Fortune Southeast Asia 500 ranks the region’s top 500 companies by total revenue, spotlighting the scale and influence of Southeast Asia’s leading businesses.
Founder and Executive Chairman of DXN, Datuk Lim Siow Jin (拿督林孝仁) in a statement adds, “We are honoured and absolutely delighted to be recognised by Fortune as one of Southeast Asia’s top 500 companies. We started small in the state of Kedah in Malaysia. This honour is a reflection of many years of dedication of everyone in DXN in manufacturing and direct selling of wellness to our customers worldwide. This achievement is a testament to the resilience of our business model and the strength of our extensive member network. It reinforces the impact we are making across several jurisdictions and markets. This recognition inspires us to reach even greater heights.”
“DXN’s inclusion in this prestigious list affirms government policies that support manufacturers with direct selling capability. Our focus moving forward remains on strengthening our market presence in high-growth regions including Latin America, the Middle East, and Asia, while exploring new opportunities across the health and wellness value chain.”
DXN’s international success is attributed to its strategically developed global manufacturing footprint. The Group operates advanced production and cultivation facilities in Malaysia, India, China, Mexico, Bangladesh, Nepal, and Dubai. These global hubs form the backbone of the Group’s self-sustaining global supply chain, enabling it to ensure consistent product quality, maintain cost efficiency and scale operations rapidly.
Today, DXN has over 19.3 million registered members across more than 180 countries who play a vital role in driving market outreach and product engagement.
Since DXN’s listing on Bursa Securities in May 2023, the Company has delivered uninterrupted year-on-year growth and dividends, continuing this momentum in the financial year ended 28 February 2025 (“FY25”) with another record revenue of RM1.9 billion. This was driven by strong sales across key markets such as Peru, Bolivia, the Middle East, and Turkey, supported by consistent marketing efforts and active member engagement throughout the year.
For FY25, DXN declared total dividends of 3.7 sen per ordinary share for FY25, amounting to RM184.0 million, equivalent to 55.9% of net profit, reaffirming its commitment to delivering shareholder value in line with its dividend policy of distributing at least 50% of net profit.
As DXN charts its path forward, the Company remains committed to delivering value through sustainable value chain with continuous innovation in health and wellness.
Disclaimer :
Please be informed that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and activity. We disclaim any liability for damages or losses resulting from the use or reliance on this content.
Health
Food and Beverage
Personal Care
Nutrition
Beauty
Branch
Business
Register